FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to compounds of formula 
(I) - oxytocin receptor agonists, to their pharmaceutical compositions containing them.
EFFECT: compounds can be used for preparing a drug for treating, among others, abdominal pain, irritable bowel syndrome (IBS), autism, erectile dysfunction, female sexual dysfunction, delivery stimulation and maintenance, lactation stimulation and maintenance, post-delivery syndrome, posttraumatic stress disorder (PTSD), pain, anxiety and other conditions.
19 cl, 1 tbl, 5 ex
| Title | Year | Author | Number |
|---|---|---|---|
| OXYTOCIN ANALOGUES | 2009 |
|
RU2496788C2 |
| ANALOGUES OF GHRELIN SUBSTITUTED AT N-END | 2007 |
|
RU2459831C2 |
| NOVEL PEPTIDE COMPOUND OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF | 2020 |
|
RU2824612C2 |
| PEPTIDE COMPOUNDS | 2007 |
|
RU2415149C2 |
| METHOD FOR CLEAVAGE OF SOLID PHASE-BOUND PEPTIDES FROM THE SOLID PHASE | 2019 |
|
RU2771712C2 |
| METHOD FOR PRODUCING PEPTIDE EXENATIDE | 2011 |
|
RU2458066C1 |
| PEPTIDES AND PHARMACEUTICAL COMPOSITIONS FOR TREATING EYE DISEASES | 2019 |
|
RU2819399C2 |
| SYNTHESIS OF LIXISENATIDE WITH CAPPING | 2019 |
|
RU2782772C2 |
| SITE-SPECIFIC MONOPHYLATED ANALYGES OF EXCENDIN AND THE METHOD OF THEIR PRODUCTION | 2012 |
|
RU2625015C2 |
| V1A-RECEPTORS AGONISTS | 2013 |
|
RU2634617C2 |
